GoldenGolden
Novogene

Novogene

Novogene provides NGS and bioinformatic services.

Novogene is a biotech company founded by Dr. Ruiqiang Li in 2011. It develops software for sequence mapping, variation detection, and genome assembly and has offices in Hong Kong, the United States and the United Kingdom.

Product

Novogene is an Illumina Genome Network partner. They offer a range of NGS-based services for human, plant, animal and microbial DNA and RNA analysis.Services offered include human genome sequencing, gene regulation, single-cell sequencing, animal and plant solutions (such as genome sequencing), and microbial genome sequencing. Pharmaceutical companies can also utilize Novogene's technology for drug development related to insights gained from genomic sequencing. The technology at the company uses various systems, such as HiSeq X, to sequence genomes, which allows for the company to annually sequence 280,000 human genomes.

Funding

In its series B round of funding in 2016, Novogene raised $75 million.

Timeline

November 30, 2016
Novogene raises a $75,000,000 series B round from China Merchants Bank.
2011
Novogene was founded by Ruiqiang Li.

Funding rounds

People

Name
Role
LinkedIn

Dr. Ruiqiang Li

Founder

Further reading

Title
Author
Link
Type
Date

New Products Posted to GenomeWeb: ChunLab, Streck, Novogene

Web

August 9, 2019

Documentaries, videos and podcasts

Title
Date
Link

Leading Edge Genomic Services & Solutions

March 28, 2019

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
June 11, 2021
WebWire
Wolters Kluwer, a global leader in professional information, software solutions and services, announced today that Novogene has selected the CCH® Tagetik corporate performance management (CPM) expert solution to help the company digitize its management financial statements so it can achieve higher data accuracy and ensure reports are delivered in a timely manner., , , , Novogene is a leading provider of genomic services and solutions with cutting edge next-generation sequencing (NGS) and b...
Wolters Kluwer
June 11, 2021
www.prnewswire.com:443
/PRNewswire/ -- Wolters Kluwer, a global leader in professional information, software solutions and services, announced today that Novogene has selected the...
June 10, 2021
WebWire
C2i Genomics, a cancer intelligence company, today announced it has signed a collaboration partnership agreement with NovogeneAIT Genomics, a leading global provider of genomic services and solutions. This partnership begins the global commercial launch of the C2-Intelligence Platform, a cancer diagnostics service that uses AI pattern recognition and whole-genome analysis to provide rapid and accurate detection of residual disease that is up to 100x more sensitive than competing technolo...
July 10, 2019
WebWire
Mission Bio, the pioneer in targeted single-cell DNA analysis and precision genomics, today announced that it has launched sales in China through a distribution agreement with Novogene, a leading provider of genomic services and solutions globally. The deal brings the Mission Bio Tapestri® Platform to the rapidly expanding Chinese market. China is one of the world's largest next-generation sequencing (NGS) markets, with enormous opportunities for genomics. Thanks to greater investment i...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.